Trial Profile

A Randomized, Placebo-Controlled, Double-Blind, Single-Dose and Multiple Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of the Gamma-Secretase Modulator BMS-932481 in Healthy Young and Elderly Individuals

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 09 Jun 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

14 Aug 2013 New trial record
14 Jul 2013 Results presented at the 2013 Alzheimer's Association International Conference .

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com